(Q54531335)

31 May 2018

title

Problems in assessment of new pharmacologic agents for the heart failure patient (English)

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Cardiology and cardiovascular medicine

8 April 2024

main subject

heart failure

0 references

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

8 April 2024

8

E Braunwald

1 reference

31 May 2018

3

W. S. Colucci

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7270403

8 April 2024

author name string

R. E. Rude

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7270403

8 April 2024

W. Grossman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7270403

8 April 2024

J. R. Benotti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7270403

8 April 2024

B. A. Carabello

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7270403

8 April 2024

J. Wynne

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7270403

8 April 2024

R. Malacoff

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7270403

8 April 2024

language of work or name

English

0 references

publication date

1 September 1981

1 reference

31 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0002870381907481?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

https://api.elsevier.com/content/article/PII:0002870381907481?httpAccept=text/plain

8 April 2024

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

8 April 2024

published in

American Heart Journal

1 reference

31 May 2018

volume

102

1 reference

31 May 2018

issue

3 Pt 2

1 reference

31 May 2018

page(s)

584-590

1 reference

31 May 2018

Improved left ventricular function during nitroprusside infusion in acute myocardial infarction

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Oral hydralazine therapy for chronic refractory heart failure

8 April 2024

2

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation

8 April 2024

3

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Nitrate therapy of heart failure in valvular heart disease. Importance of resting level of peripheral vascular resistance in determining cardiac output response

8 April 2024

4

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Vasodilator therapy--a physiologic approach to the treatment of heart failure

8 April 2024

5

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Dopamine — Clinical Uses of an Endogenous Catecholamine

8 April 2024

6

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Dobutamine: A New Synthetic Cardioactive Sympathetic Amine

8 April 2024

7

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Hemodynamic assessment of amrinone. A new inotropic agent

8 April 2024

8

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Oral amrinone in refractory congestive heart failure

8 April 2024

9

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man

8 April 2024

10

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure.

8 April 2024

11

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Measurement of coronary sinus blood flow by continuous thermodilution in man

8 April 2024

14

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Regional ejection fraction: a quantative radionuclide index of regional left ventricular performance

8 April 2024

15

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.

8 April 2024

16

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure

8 April 2024

17

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

New cardiotonic agents: a search for digitalis substitute

8 April 2024

18

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Cardiotonic activity of amrinone--Win 40680 [5-amino-3,4'-bipyridine-6(1H)-one]

8 April 2024

19

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin

8 April 2024

20

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Long-term therapy of heart failure with prazosin: a randomized double blind trial

8 April 2024

21

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Combined dopamine and nitroprusside therapy in congestive heart failure. Greater augmentation of cardiac performance by addition of inotropic stimulation to afterload reduction

8 April 2024

22

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Hemodynamic effects of nitroglycerin in acute myocardial infarction

8 April 2024

23

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction

8 April 2024

24

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure

8 April 2024

25

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Hemodynamic determinants of the maximal rate of rise of left ventricular pressure

8 April 2024

26

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Usefulness and limitations of the rate of rise of intraventricular pressure (dp-dt) in the evaluation of myocardial contractility in man

8 April 2024

27

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Effects of sodium nitroprusside on left ventricular diastolic pressure-volume relations

8 April 2024

29

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Control of myocardial oxygen consumption: physiologic and clinical considerations

8 April 2024

30

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Effect of Isoproterenol, l -Norepinephrine, and Intraaortic Counterpulsation on Hemodynamics and Myocardial Metabolism in Shock following Acute Myocardial Infarction

8 April 2024

31

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Effect of dopamine on hemodynamics and myocardial metabolism in shock following acute myocardial infarction in man

8 April 2024

32

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Factors influencing infarct size following experimental coronary artery occlusions

8 April 2024

33

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Effects of amrinone on experimental acute myocardial ischaemic injury

8 April 2024

34

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Attenuation of Prazosin Effect on Cardiac Output in Chronic Heart Failure

8 April 2024

36

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure

8 April 2024

37

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Effect of prazosin vs placebo on chronic left ventricular heart failure

8 April 2024

38

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Efficacy of trimazosin and prazosin therapy on cardiac and exercise performance in outpatients with chronic congestive heart failure

8 April 2024

39

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

Immediate effects of hydralazine-isosorbide dinitrate combination on exercise capacity and exercise hemodynamics in patients with left ventricular failure

8 April 2024

40

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90748-1

8 April 2024

Identifiers

1 reference

31 May 2018

1 reference

31 May 2018